Literature DB >> 8440904

Growth regulation of cultured human nevus cells.

M L Mancianti1, T Györfi, I M Shih, I Valyi-Nagy, G Levengood, H D Menssen, A C Halpern, D E Elder, M Herlyn.   

Abstract

Cells isolated from congenital melanocytic nevi and cultured in vitro have growth characteristics that resemble their premalignant stage in situ. A serum-free, chemically defined medium has been developed that allows continuous growth of established nevus cultures for up to several months. Like primary melanoma cells, nevus cells in high-calcium-containing W489 medium require insulin for growth. In contrast to melanoma cells, nevus cells in serum-free medium require the presence of alpha-melanocyte-stimulating hormone, which enhanced intracellular levels of cyclic adenosine monophosphate. In contrast to the requirements of normal human melanocytes from newborn foreskin, congenital nevus cells grow with less dependency on basic fibroblast growth factor (bFGF). Nevus cultures contain bFGF-like activity, and they express bFGF mRNA. Nevic cells of compound nevi also express bFGF mRNA in situ but only in the junctional areas. These results indicate that bFGF plays an important growth regulatory role for nevus cells in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440904     DOI: 10.1111/1523-1747.ep12470161

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  Human melanoma progression in skin reconstructs : biological significance of bFGF.

Authors:  F Meier; M Nesbit; M Y Hsu; B Martin; P Van Belle; D E Elder; G Schaumburg-Lever; C Garbe; T M Walz; P Donatien; T M Crombleholme; M Herlyn
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 2.  Moles and melanoma--new method in the madness.

Authors:  R L Barnhill
Journal:  West J Med       Date:  1994-04

3.  Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway.

Authors:  Dipanjan Basu; Cláudia M Salgado; Bruce S Bauer; Donald Johnson; Veronica Rundell; Marina Nikiforova; Yasmin Khakoo; Lorelei J Gunwaldt; Ashok Panigrahy; Miguel Reyes-Múgica
Journal:  Neuro Oncol       Date:  2015-09-09       Impact factor: 12.300

4.  Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides.

Authors:  Z Abdel-Malek; V B Swope; I Suzuki; C Akcali; M D Harriger; S T Boyce; K Urabe; V J Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

5.  Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes.

Authors:  I M Shih; D E Elder; M Y Hsu; M Herlyn
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

6.  Transcriptome Analysis of Large to Giant Congenital Melanocytic Nevus Reveals Cell Cycle Arrest and Immune Evasion: Identifying Potential Targets for Treatment.

Authors:  Boxuan Wei; Jieyu Gu; Ran Duan; Bowen Gao; Min Wu; Shengliang Zhou; Xiaolu Huang; Feng Xie
Journal:  J Immunol Res       Date:  2021-12-06       Impact factor: 4.818

Review 7.  Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma.

Authors:  Thomas Bogenrieder; Meenhard Herlyn
Journal:  Crit Rev Oncol Hematol       Date:  2002-10       Impact factor: 6.312

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.